author-photo

Stacey Green

University of California, Los Angeles

9

Papers

388

Citations

Citation Trend

Filter By

Papers (9) Sort By

JournalConferenceOthers

CTNI-14. EVALUATING METABOLIC ALTERATIONS IN PATIENTS WITH EGFR ACTIVATED RECURRENT GLIOBLASTOMA (RGBM) BY INHIBITING EGFR WITH OSIMERTINIB

2021 Neuro-oncology
Show All
- Source
- Cite
- Save
Citations (0)
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

2021 The Lancet
Show All
- Source
- Cite
- Save
Citations (341)
Phase 2 Study of Bortezomib Combined With Temozolomide and Regional Radiation Therapy for Upfront Treatment of Patients With Newly Diagnosed Glioblastoma Multiforme: Safety and Efficacy Assessment

2018 International Journal of Radiation Oncology Biology Physics
Show All
- Source
- Cite
- Save
Citations (27)
ACTR-89. KARNOFSKY PERFORMANCE STATUS AND STEROID USE IN PHASE II TRIAL OF BEVACIZUMAB AND TEMOZOLOMIDE FOR UPFRONT TREATMENT OF ELDERLY PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA

2017 Neuro-oncology
Show All
- Source
- Cite
- Save
Citations (0)
Report of safety of pulse dosing of lapatinib with temozolomide and radiation therapy for newly-diagnosed glioblastoma in a pilot phase II study

2017 Journal of Neuro-oncology
Show All
- Source
- Cite
- Save
Citations (14)
Pilot study of pulse high-dose lapatinib in combination with temozolomide (TMZ) and radiotherapy (RT) for upfront treatment of glioblastoma (GBM).

2014 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
MEDICAL RADIATION THERAPIES

2013 Neuro-oncology
Show All
- Source
- Cite
- Save
Citations (0)
Mr-016. Phase Ii Pilot Study Of Velcade® (bortezomib) In Combination With Temozolomide And Regional Radiation Therapy For Upfront Treatment Of Patients With Newly-diagnosed Glioblastoma Multiforme

2013 Neuro-oncology
Show All
- Source
- Cite
- Save
Citations (1)
CLIN-ONGOING CLINICAL TRIALS

2012 Neuro-oncology
Show All
- Source
- Cite
- Save
Citations (5)

© Copyright 2015-2020 Acemap, Inc. Shanghai Jiao Tong University.

沪ICP备18028330号